Remove Article Remove FDA Remove Governance Remove World Health
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S The World Health Organization supports this ban and in particular describes it as making informed consent impossible in the health care setting. While the U.S.

article thumbnail

Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation

Bill of Health

Both Robert and Valentina Wasson published sensational magazine articles in Life! federal government remained unresponsive to the wealth of evidence supporting the therapeutic use of psychedelics. and This Week, respectively, along with subsequent texts that exposed María Sabina without consent, credit, or compensation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How the Medical Industry Can Help Combat the Current Coronavirus Crisis

Exeed Regulatory Compliance

It rapidly caused a widespread epidemic in China and has spread to over 50 countries outside of China with more than 90,000 confirmed cases and 3000 deaths at the time of this blog article. Secretary of the Department of Health and Human Services (HHS) has declared a public health emergency.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. The application/notification must be submitted via the EUDAMED database (Article 69 IVDR).

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

The US FDA has already recognized the ability of 16 EU Member States to conduct GMP inspections of manufacturers of veterinary medicinal products. At the same time, the EU has recognized the US FDA as an equivalent authority to carry out these inspections. The addition of Annex 2, which describes the CPCA for N -nitrosamines.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – May

SQA

It is not intended to provide information on the terms and procedures directly associated with regulatory requirements governing cell-based products. World Health Organization (WHO). 1, 2022 edition of the Newsletter includes a short article on the recent Advisory Committee on Safety of Medicinal Products (ACSoMP) meeting. .

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

List Health Advance as an “Official Canadian Distributor” Include the text “Health Canada Approved” (Claims of endorsement by government authorities, such as Health Canada, are not permitted.). Counterfeit health products are imitations of authentic products. .” instead of BTNX Inc.